Piramal Pharma Limited

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023-04 to 2024-03🗂️ Report periods on file: 2023-04 to 2024-03

In its 2023-04 to 2024-03 reporting, Piramal Pharma Limited disclosed greenhouse gas emissions of 56.2K +79415+499659 = 635204 tCO2e/year. By scope: Scope 1: 56.2K tCO2e/year; Scope 2: 79.4K tCO2e/year; Scope 3: 499.7K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
56.2K +79415+499659 = 635204 tCO2e/year
2023-04 to 2024-03
⚡
Renewable Energy
10% (India), 6% (Global)
of total energy
💧
Water Usage
586.9K m3/year
2023-04 to 2024-03
♻️
Waste
14.6K +18640 = 33203 tons/year
2023-04 to 2024-03

📊 Emissions by Scope (2023-04 to 2024-03)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).56.2K tCO2e/year
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.79.4K tCO2e/year
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).499.7K tCO2e/year

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce water consumption by 400 KLD

📅 Medium-term

  • Reduce absolute Scope 1 and Scope 2 emissions by 42% by 2030 from the 2022 baseline
  • Reduce absolute Scope 3 emissions by 25% by 2030 from the 2022 baseline
  • Achieve 26% renewable energy in India and 19% globally by FY 2026

🔭 Long-term

  • Net zero emissions

🌱 ESG Focus Areas

Business ResilienceQuality and ExcellenceResponsible OperationsStakeholder Centricity

⚠️ Challenges & Risks +

  • Continued stress in the biotech funding environment
  • Global supply chain disturbances
  • Customer and product concentration risk
  • Site concentration risk
  • Clinical or regulatory attrition risk
  • Third-party manufacturing and quality risk
  • Talent acquisition and retention risk
  • Environmental risks
  • IT and cyber risks
  • Capex project management risk

📋 Report Information

Reporting Period: 2023-04 to 2024-03
Frameworks: GRI Universal Standards 2021, UN Sustainable Development Goals
Assurance: DNV Business Assurance India Private Limited